Bausch Health Companies (BHC) Minority Interest (2013 - 2026)
Bausch Health Companies (BHC) posted Minority Interest of $969.0 million for Q2 2026, down 0.82% sequentially from $977.0 million in Q1 2026, and up 6.37% YoY from $911.0 million in Q2 2025.
Bausch Health Companies (BHC) Minority Interest (2013 - 2026) Analysis & Trends
Bausch Health Companies has reported Minority Interest for 14 years, with the latest figure at $969.0 million in Q2 2026.
- Quarterly Minority Interest rose 6.37% year-over-year to $969.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $969.0 million (up 6.37% YoY) and the FY2025 annual result came in at $931.0 million, down 2.72% from the prior year.
- Minority Interest retreated to $969.0 million in Q2 2026 per BHC's latest filing, from $977.0 million in the prior quarter.
- Over five years, Minority Interest peaked at $977.0 million in Q1 2026 and troughed at $75.0 million in Q1 2022.
- A 5-year average of $895.8 million and a median of $944.0 million in 2023 frame the typical range for Minority Interest.
- The sharpest annual moves came in 2022 and 2025: Minority Interest surged 1288.41% in 2022, then decreased 3.9% in 2025.
- Over 5 years, Minority Interest stood at $952.0 million in 2022, then decreased by 1.26% to $940.0 million in 2023, then grew by 1.81% to $957.0 million in 2024, then decreased by 2.72% to $931.0 million in 2025, then advanced by 4.08% to $969.0 million in 2026.
- According to Business Quant data, Minority Interest over the past three periods registered $969.0 million, $977.0 million, and $931.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Bausch Health Companies | 2.42 Bn | 586.38 Mn | 2.10 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 969.00 Mn |
| Mar 31, 2026 | 977.00 Mn |
| Dec 31, 2025 | 931.00 Mn |
| Sep 30, 2025 | 921.00 Mn |
| Jun 30, 2025 | 911.00 Mn |
| Mar 31, 2025 | 943.00 Mn |
| Dec 31, 2024 | 957.00 Mn |
| Sep 30, 2024 | 932.00 Mn |
| Jun 30, 2024 | 948.00 Mn |
| Mar 31, 2024 | 941.00 Mn |
| Dec 31, 2023 | 940.00 Mn |
| Sep 30, 2023 | 945.00 Mn |
| Jun 30, 2023 | 934.00 Mn |
| Mar 31, 2023 | 945.00 Mn |
| Dec 31, 2022 | 952.00 Mn |
| Sep 30, 2022 | 958.00 Mn |
| Jun 30, 2022 | 946.00 Mn |
| Mar 31, 2022 | 75.00 Mn |
| Dec 31, 2021 | 72.00 Mn |
| Sep 30, 2021 | 69.00 Mn |